Bantam Pharmaceutical
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
505 Park Ave, New York City, New York, 1...Phone Number
(646) 598-4823Website
www.bantampharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Bantam Pharmaceutical
Bantam Pharma is focused on redefining cancer care by developing novel, first-in-class small molecule oral therapeutics aimed at difficult-to-treat hematological and solid tumors. Their lead candidate, BTM-3566, targets cancer cells by restoring apoptosis, showing promising results in preclinical studies, particularly against Diffuse Large B-cell Lymphoma. The company leverages its expertise in mitochondrial dynamics to innovate cancer treatment and is actively seeking partners and investors for clinical development. With a capital-efficient operating model, Bantam Pharma is positioned for aggressive product development in the oncology sector.Explore more
Bantam Pharmaceutical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bantam Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Bantam Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Bantam Pharmaceutical launches new products
Earning: See what the market has to say on Bantam Pharmaceutical recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Bantam Pharmaceutical has new funding data
Congratulate Masked Content for being promoted to Masked Content at Bantam Pharmaceutical
Click to see if Bantam Pharmaceutical had a recent Job posting/layoffs
Check out if Bantam Pharmaceutical is spiking on competitors!
Bantam Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Bantam Pharmaceutical
Compare insights from companies similar to Bantam Pharmaceutical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bantam Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bantam Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bantam Pharmaceutical.
Bantam Pharmaceutical financials insights
Gather financial insights about Bantam Pharmaceutical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$25M
Bantam Pharmaceutical Tech Stack
A closer look at the technologies used by Bantam Pharmaceutical
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
Bantam Pharmaceutical News & Media
Bantam Pharmaceutical Announces Activation of First Phase 1 Clinical Trial Site at MD Anderson Cancer Center
RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2025 /PRNewswire/ -- Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today announced the activation of its first clinical trial site at The University of Texas MD...BANTAM PHARMACEUTICAL TO PRESENT AT BIOTECH SHOWCASE™ 2023
Developing Novel Selective Modulators of Mitochondrial Dynamics (SeMMiDs) A differentiated therapeutic approach for treating aggressive cancer RALEIGH, N.C., Jan. 9, 2023 /PRNewswire/ -- Bantam Pharmaceutical, LLC announces that it is presenting at the Biotech Showcase taking place in San...Bantam Pharmaceutical and Collaborators to Present New Data in Support of its Clinical Candidate BTM-3566 at Third AACR International Meeting - Advances in Malignant Lymphoma
RESEARCH TRIANGLE PARK, N.C., June 23, 2022 /PRNewswire/ -- Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, announced that new data on the mechanism of action of its lead clinical candidate BTM-3566 will...Bantam Pharmaceutical and Collaborators to Present New Data in Support of its lead drug BTM-3566 at AACR Annual Meeting 2022
RESEARCH TRIANGLE PARK, N.C., April 8, 2022 /PRNewswire/ -- Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, will present new data on its lead drug candidate BTM-3566 at AACR 2022 taking place the 8th-13th...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bantam Pharmaceutical
Sign Up For FreeTo access detailed company insights
Bantam Pharma is focused on redefining cancer care by developing novel, first-in-class small molecule oral therapeutics aimed at difficult-to-treat hematological and solid tumors. Their lead candidate, BTM-3566, targets cancer cells by restoring apoptosis, showing promising results in preclinical studies, particularly against Diffuse Large B-cell L... Read More
